Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: INT025
MIFTS: 41

Intermittent Explosive Disorder

Categories: Mental diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Intermittent Explosive Disorder

About this section

MalaCards integrated aliases for Intermittent Explosive Disorder:

Name: Intermittent Explosive Disorder 12 15 74
Explosive Personality Disorder 12 74

Classifications:

MalaCards categories:
Anatomical: Mental diseases
See all MalaCards categories (disease lists)
ICD10: 34


External Ids:

Disease Ontology 12 DOID:12401
ICD9CM 36 301.3 312.34
MeSH 45 D007174
NCIt 51 C94332
SNOMED-CT 69 40987004
ICD10 34 F60.3 F63.81
Sources

Summaries for Intermittent Explosive Disorder

About this section
Disease Ontology : 12 An impulse control disorder that involves the episodic inability to control violent impulses with a disproportionate degree of aggressiveness.

MalaCards based summary : Intermittent Explosive Disorder, also known as explosive personality disorder, is related to personality disorder and anxiety. An important gene associated with Intermittent Explosive Disorder is SLC6A4 (Solute Carrier Family 6 Member 4), and among its related pathways/superpathways are Peptide ligand-binding receptors and Glucocorticoid receptor regulatory network. The drugs Guanfacine and Naratriptan have been mentioned in the context of this disorder. Affiliated tissues include heart, amygdala and brain, and related phenotypes are growth/size/body region and homeostasis/metabolism

Wikipedia : 77 Intermittent explosive disorder (sometimes abbreviated as IED) is a behavioral disorder characterized by... more...

Sources

Related Diseases for Intermittent Explosive Disorder

About this section

Diseases related to Intermittent Explosive Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 70)
# Related Disease Score Top Affiliating Genes
1 personality disorder 30.5 HTR1A PRL SLC6A4
2 anxiety 30.1 HTR1A NPY SLC6A4
3 disease of mental health 30.0 HTR1A IL6 SLC6A4
4 obsessive-compulsive disorder 29.9 HTR1A PRL SLC6A4
5 alcohol abuse 29.5 GABRA2 PRL SLC6A4
6 major depressive disorder 29.1 HTR1A IL6 NPY PRL SLC6A4
7 pyromania 11.3
8 psychosexual disorder 10.3 HTR1A SLC6A4
9 phobic disorder 10.3 HTR1A SLC6A4
10 kleptomania 10.3 HTR1A SLC6A4
11 periodic limb movement disorder 10.3 HTR1A SLC6A4
12 premature ejaculation 10.3 HTR1A SLC6A4
13 cold agglutinin disease 10.2 CRP IL6
14 cryopyrin-associated periodic syndrome 10.2 CRP IL6
15 alexithymia 10.2 CRP HTR1A SLC6A4
16 acute cholangitis 10.1 CRP IL6
17 uremic pruritus 10.1 CRP IL6
18 neutrophilia, hereditary 10.1 CRP IL6
19 sphenoid sinusitis 10.1 CRP GOLPH3
20 spinal disease 10.1 CRP IL6
21 endogenous depression 10.1 HTR1A NPY SLC6A4
22 viral pneumonia 10.1 CRP IL6
23 multicentric castleman disease 10.1 CRP IL6
24 bipolar disorder 10.1
25 relapsing polychondritis 10.1 CRP IL6
26 central nervous system vasculitis 10.1 CRP IL6
27 subacute thyroiditis 10.1 CRP IL6
28 chronic fatigue syndrome 10.1 HTR1A IL6 SLC6A4
29 intussusception 10.1 CRP IL6
30 louse-borne relapsing fever 10.1 CRP IL6
31 migraine with or without aura 1 10.1 GOLPH3 HTR1A SLC6A4
32 cecal disease 10.1 CRP IL6
33 stereotypic movement disorder 10.1 NPY PRL
34 cluster headache 10.0 NPY PRL
35 pyelitis 10.0 CRP IL6
36 social phobia 10.0 HTR1A PRL SLC6A4
37 sexual disorder 10.0 HTR1A PRL SLC6A4
38 migraine without aura 10.0 HTR1A PRL SLC6A4
39 ischemic heart disease 10.0 CRP IL6
40 mesenteric lymphadenitis 10.0 CRP IL6
41 viral meningitis 10.0 CRP IL6
42 anovulation 10.0 CGA CRP PRL
43 spinocerebellar degeneration 10.0 NPY PRL
44 systolic heart failure 10.0 ADRB1 CRP IL6
45 agoraphobia 10.0 HTR1A SLC6A4
46 mycoplasma pneumoniae pneumonia 10.0 CRP IL6
47 prader-willi syndrome 10.0
48 cognitive function 1, social 10.0
49 paraphilia disorder 10.0
50 borderline personality disorder 10.0

Comorbidity relations with Intermittent Explosive Disorder via Phenotypic Disease Network (PDN):


Acute Cystitis Alzheimer Disease
Schizophreniform Disorder

Graphical network of the top 20 diseases related to Intermittent Explosive Disorder:



Diseases related to Intermittent Explosive Disorder
Sources

Symptoms & Phenotypes for Intermittent Explosive Disorder

About this section

MGI Mouse Phenotypes related to Intermittent Explosive Disorder:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 9.61 ADRB1 AURKA CGA CHRNA7 CTSH IL6
2 homeostasis/metabolism MP:0005376 9.32 ADRB1 CGA CHRNA7 CRP GABRA2 HTR1A
Sources

Drugs & Therapeutics for Intermittent Explosive Disorder

About this section

Drugs for Intermittent Explosive Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 50)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Guanfacine Approved, Investigational Phase 4 29110-47-2 3519
2
Naratriptan Approved, Investigational Phase 4 143388-64-1, 121679-13-8 4440
3 Adrenergic alpha-Agonists Phase 4
4 Adrenergic Agonists Phase 4
5 Adrenergic Agents Phase 4
6 Antihypertensive Agents Phase 4
7 Adrenergic alpha-2 Receptor Agonists Phase 4
8 Neurotransmitter Agents Phase 4,Phase 3,Phase 2
9 Vasoconstrictor Agents Phase 4,Phase 1,Phase 2
10 Serotonin Agents Phase 4,Phase 3,Phase 2
11 Serotonin 5-HT1 Receptor Agonists Phase 4
12 Serotonin Receptor Agonists Phase 4
13
Serotonin Investigational, Nutraceutical Phase 4,Phase 3,Phase 2 50-67-9 5202
14
Risperidone Approved, Investigational Phase 3 106266-06-2 5073
15
Dopamine Approved Phase 3 62-31-7, 51-61-6 681
16
Carbidopa Approved Phase 3 28860-95-9 34359
17
Levodopa Approved Phase 3 59-92-7 6047
18 Central Nervous System Depressants Phase 3,Not Applicable
19 Serotonin Antagonists Phase 3
20 Tranquilizing Agents Phase 3
21 Dopamine Agents Phase 3
22 Antipsychotic Agents Phase 3
23 Psychotropic Drugs Phase 3,Phase 2
24 Dopamine Antagonists Phase 3
25 Adjuvants, Immunologic Phase 3
26 Antiparkinson Agents Phase 3
27 Immunologic Factors Phase 3
28 Dopamine agonists Phase 3
29 Aromatic Amino Acid Decarboxylase Inhibitors Phase 3
30 Carbidopa, levodopa drug combination Phase 3
31
Fluoxetine Approved, Vet_approved Phase 2 54910-89-3 3386
32
Quinidine Approved, Investigational Phase 2 56-54-2 441074
33 Arginine Vasopressin Phase 1, Phase 2
34 Coagulants Phase 1, Phase 2
35 Natriuretic Agents Phase 1, Phase 2
36 Hemostatics Phase 1, Phase 2
37 Antidiuretic Hormone Receptor Antagonists Phase 1, Phase 2
38 Hormones Phase 1, Phase 2
39 SRX246 Phase 1, Phase 2
40 Vasopressins Phase 1, Phase 2
41 Cytochrome P-450 Enzyme Inhibitors Phase 2
42 Neurotransmitter Uptake Inhibitors Phase 2
43 Serotonin Uptake Inhibitors Phase 2
44 Antidepressive Agents, Second-Generation Phase 2
45 Antidepressive Agents Phase 2
46 Cytochrome P-450 CYP2D6 Inhibitors Phase 2
47 Quinidine gluconate Phase 2
48
Ethanol Approved Not Applicable 64-17-5 702
49 Anti-Infective Agents Not Applicable
50 Anti-Infective Agents, Local Not Applicable

Interventional clinical trials:

(show all 11)
# Name Status NCT ID Phase Drugs
1 Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder Completed NCT02048241 Phase 4 Intuniv
2 Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order Terminated NCT00282165 Phase 4 naratriptan;placebo
3 Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone. Completed NCT00399698 Phase 3 Risperdal
4 Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects Completed NCT00360568 Phase 3 Levodopa-carbidopa intestinal gel
5 Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease Completed NCT00335153 Phase 3 Levodopa-carbidopa intestinal gel
6 Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder Completed NCT02055638 Phase 1, Phase 2 SRX246;Placebo
7 Psychotherapy for Intermittent Explosive Disorder Completed NCT00667212 Phase 2
8 A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder Completed NCT00078754 Phase 2 Fluoxetine;Divalproex;Placebo
9 A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With IED Completed NCT00127400 Phase 2
10 Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder Terminated NCT03420222 Phase 2 AVP-786;Placebo
11 Alcohol Related Impairment and Reinforcement: Pre to Post Roux en Y Gastric Bypass Surgery Recruiting NCT02370732 Not Applicable

Search NIH Clinical Center for Intermittent Explosive Disorder

Sources

Genetic Tests for Intermittent Explosive Disorder

About this section
Sources

Anatomical Context for Intermittent Explosive Disorder

About this section

MalaCards organs/tissues related to Intermittent Explosive Disorder:

42
Heart, Amygdala, Brain, Thyroid
Sources

Publications for Intermittent Explosive Disorder

About this section

Articles related to Intermittent Explosive Disorder:

(show top 50) (show all 102)
# Title Authors Year
1
Emotion processing in intermittent explosive disorder. ( 30710810 )
2019
2
Aggression directed towards others vs. aggression directed towards the self: clinical differences between intermittent explosive disorder and nonsuicidal self-injury. ( 30843959 )
2019
3
The co-occurrence and correlates of anxiety disorders among adolescents with intermittent explosive disorder. ( 30040122 )
2018
4
A wait-list controlled study of a trauma-focused cognitive behavioral treatment for intermittent explosive disorder in Timor-Leste. ( 28749158 )
2018
5
Genome-Wide DNA Methylation Changes Associated with Intermittent Explosive Disorder: A Gene-Based Functional Enrichment Analysis. ( 29106553 )
2018
6
Major depressive disorder and depressive symptoms in intermittent explosive disorder. ( 29455060 )
2018
7
Treatment of Intermittent Explosive Disorder With Carbamazepine. ( 29533363 )
2018
8
Cognitive-behavioral group therapy for intermittent explosive disorder: description and preliminary analysis. ( 29590263 )
2018
9
Prevalence and clinical correlates of intermittent explosive disorder in Turkish psychiatric outpatients. ( 29604524 )
2018
10
Psychosocial impairment in DSM-5 intermittent explosive disorder. ( 29627702 )
2018
11
DSM-5 intermittent explosive disorder: Relationship with Disruptive Mood Dysregulation Disorder. ( 29753187 )
2018
12
Comorbidity of personality disorder with intermittent explosive disorder. ( 30240963 )
2018
13
Social desirability, deceptive reporting, and awareness of problematic aggression in intermittent explosive disorder compared with non-aggressive healthy and psychiatric controls. ( 30243128 )
2018
14
Subtypes of aggression in intermittent explosive disorder. ( 30551023 )
2018
15
Development of a screening questionnaire for DSM-5 intermittent explosive disorder (IED-SQ). ( 28088746 )
2017
16
Intermittent Explosive Disorder and Substance Use Disorder: Analysis of the National Comorbidity Survey Replication Sample. ( 28252880 )
2017
17
Intermittent explosive disorder and eating disorders: Analysis of national comorbidity and research samples. ( 28324677 )
2017
18
Elevated Plasma Oxidative Stress Markers in Individuals With Intermittent Explosive Disorder and Correlation With Aggression in Humans. ( 24582164 )
2016
19
Effects of Escitalopram Administration on Face Processing in Intermittent Explosive Disorder: An fMRI Study. ( 26105140 )
2016
20
Prevalence of DSM-IV intermittent explosive disorder in Black adolescents: Findings from the National Survey of American Life, Adolescent Supplement. ( 27078052 )
2016
21
Defense styles in Intermittent Explosive Disorder. ( 27086223 )
2016
22
Amygdala hyperactivation to angry faces in intermittent explosive disorder. ( 27145325 )
2016
23
Negative urgency and reward/punishment sensitivity in intermittent explosive disorder. ( 27155024 )
2016
24
Single Case Study: Neuropsychological Functioning in a Patient Diagnosed with Intermittent Explosive Disorder Pre and Post Neurosurgery. ( 27161981 )
2016
25
White Matter Integrity Reductions in Intermittent Explosive Disorder. ( 27206265 )
2016
26
Substance use disorders: Relationship with intermittent explosive disorder and with aggression, anger, and impulsivity. ( 27442963 )
2016
27
The cross-national epidemiology of DSM-IV intermittent explosive disorder. ( 27572872 )
2016
28
Social cognition in Intermittent Explosive Disorder and aggression. ( 27621104 )
2016
29
Comorbid intermittent explosive disorder and posttraumatic stress disorder: Clinical correlates and relationship to suicidal behavior. ( 27624432 )
2016
30
Differential fMRI BOLD responses in amygdala in intermittent explosive disorder as a function of past Alcohol Use Disorder. ( 27693977 )
2016
31
Frontolimbic Morphometric Abnormalities in Intermittent Explosive Disorder and Aggression. ( 29560894 )
2016
32
Self-harm behavior among individuals with intermittent explosive disorder and personality disorders. ( 25300440 )
2015
33
Emotional intelligence and impulsive aggression in Intermittent Explosive Disorder. ( 25477263 )
2015
34
Verbal versus physical aggression in Intermittent Explosive Disorder. ( 25534757 )
2015
35
The experience of aggressive outbursts in Intermittent Explosive Disorder. ( 25541537 )
2015
36
The coherence and correlates of intermittent explosive disorder amongst West Papuan refugees displaced to Papua New Guinea. ( 25754605 )
2015
37
Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder. ( 26277033 )
2015
38
Emotion regulation deficits in intermittent explosive disorder. ( 27539871 )
2015
39
Doing Psychiatry Right: A Case of Severe Avoidant Personality Disorder with Obsessive-compulsive Personality Disorder, Obsessive Compulsive Disorder, Intermittent Explosive Disorder and Sexual Paraphilias. ( 25035563 )
2014
40
Validity of the new A1 and A2 criteria for DSM-5 intermittent explosive disorder. ( 24321204 )
2014
41
Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. ( 24352431 )
2014
42
Intermittent explosive disorder: a study in personalized psychopharmacotherapy. ( 24441311 )
2014
43
Relationship between psychopathy, aggression, anger, impulsivity, and intermittent explosive disorder. ( 24760575 )
2014
44
Intermittent explosive disorder: associations with PTSD and other Axis I disorders in a US military veteran sample. ( 24907536 )
2014
45
History of childhood maltreatment in intermittent explosive disorder and suicidal behavior. ( 24935900 )
2014
46
Intermittent Explosive Disorder and aversive parental care. ( 25064384 )
2014
47
Common and distinct neural correlates of inhibitory dysregulation: stroop fMRI study of cocaine addiction and intermittent explosive disorder. ( 25106072 )
2014
48
Intermittent explosive disorder and DSM-5: a flawed conceptualization of pathological anger. ( 23719736 )
2013
49
Achieving convergence between a community-based measure of explosive anger and a clinical interview for intermittent explosive disorder in Timor-Leste. ( 23835102 )
2013
50
Intermittent explosive disorder amongst women in conflict affected Timor-Leste: associations with human rights trauma, ongoing violence, poverty, and injustice. ( 23950885 )
2013
Sources

Variations for Intermittent Explosive Disorder

About this section
Sources

Expression for Intermittent Explosive Disorder

About this section
Search GEO for disease gene expression data for Intermittent Explosive Disorder.
Sources

GO Terms for Intermittent Explosive Disorder

About this section

Biological processes related to Intermittent Explosive Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of signaling receptor activity GO:0010469 9.76 CGA IL6 NPY PRL
2 positive regulation of gene expression GO:0010628 9.73 CRP CTSH IL6 SLC6A4
3 positive regulation of JAK-STAT cascade GO:0046427 9.48 IL6 PRL
4 chemical synaptic transmission GO:0007268 9.46 CHRNA7 GABRA2 HTR1A NPY
5 cell proliferation GO:0008283 9.4 GOLPH3 HTR1A
6 vasoconstriction GO:0042310 9.37 HTR1A SLC6A4
7 negative regulation of organ growth GO:0046621 9.32 CGA SLC6A4
8 negative regulation of lipid storage GO:0010888 9.26 CRP IL6
9 regulation of postsynaptic membrane potential GO:0060078 9.13 ADRB1 CHRNA7 GABRA2
10 positive regulation of cell proliferation GO:0008284 9.1 CGA CHRNA7 CTSH HTR1A IL6 PRL

Molecular functions related to Intermittent Explosive Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 9.13 CGA NPY PRL
2 serotonin binding GO:0051378 8.62 HTR1A SLC6A4
Sources

Sources for Intermittent Explosive Disorder

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....